DaehanPharmaceutical Chairman Lee Yun-woo Increases Stake by 0.08p via Open Market Purchases

Lee Yun-woo, Chairman and controlling shareholder of DaehanPharmaceutical, increased his stake from 24.81% to 24.89% by purchasing 4,499 shares on the open market from June 23 to 30, 2026.
The purchase prices ranged from 24,338 to 25,510 won per share, reflecting market price levels, and this minor increase signals insider buying confidence.
This report is a routine disclosure of changes in ownership by executives and major shareholders, unrelated to any corporate capital events or financing activities.
[AI Summary]The chairman's modest stake increase suggests management confidence but the 0.08 percentage point increment is too small to drive significant price momentum. No capital structure changes or dividend policy adjustments occurred, limiting the immediate impact on shareholder value.